Skip to main content

Table 8 Results of % assay of the tablet dosage form

From: An effective stability indicating RP-HPLC method for simultaneous estimation of Dolutegravir and Lamivudine in bulk and their tablet dosage form

DrugPeak nameRTPeak areaUSP tailingUSP plate countLabel claim (mg)%assay
DolutegravirStandard5.06841854471.0590235099.5
Test5.06541313071.059923 
LamivudineStandard3.349106997681.05992330099.64
Test3.34107137461.0610022
  1. Average wt of the tablet 401 mg, % purity of Lamivudine standard (API) 99.3, and % purity of Dolutegravir standard (API) 99.4